Tropomyosin receptor kinases B and C are tumor progressive and metastatic marker in colorectal carcinoma

Human Pathology

Volumn 44, Issue 6, 2013, Pages 1098-1106

  Sasahira, Tomonori ^a   Ueda, Nobuhiro ^b   Kurihara, Miyako ^a,b   Matsushima, Sayako ^a   Ohmori, Hitoshi ^a   Fujii, Kiyomu ^a   Bhawal, Ujjal K ^a   Yamamoto, Kazuhiko ^b   Kirita, Tadaaki ^b   Kuniyasu, Hiroki ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

^b NARA MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Colon cancer; Liver metastasis; Nodal metastasis; Peritoneal metastasis; Trk

Indexed keywords

PHOSPHOTRANSFERASE; TRANSFORMING GROWTH FACTOR BETA; TROPOMYOSIN; TROPOMYOSIN RECEPTOR KINASE B; TROPOMYOSIN RECEPTOR KINASE C; TUMOR MARKER; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN A; VASCULOTROPIN C;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER STAGING; CELL GROWTH; COLORECTAL CARCINOMA; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; PERITONEUM METASTASIS; PROTEIN EXPRESSION; TUMOR INVASION;

AGED; CARCINOMA; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM METASTASIS; RECEPTOR, TRKB; RECEPTOR, TRKC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR MARKERS, BIOLOGICAL;

EID: 84878114522     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2012.09.016     Document Type: Article

References (35)

1. J. Weitz, M. Koch, J. Debus, T. Hohler, P.R. Galle, and M.W. Buchler Colorectal cancer Lancet 365 2005 153 165
2. D.M. Parkin, F. Bray, J. Ferlay, and P. Pisani Global cancer statistics, 2002 CA Cancer J Clin 55 2005 74 108
3. H.Y. Lee, H.J. Choi, and K.J. Park Prognostic significance of metastatic lymph node ratio in node-positive colon carcinoma Ann Surg Oncol 14 2007 1712 1717
4. J.B. O'Connell, M.A. Maggard, and C.Y. Ko Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging J Natl Cancer Inst 96 2004 1420 1425
5. N. Halama, S. Michel, and M. Kloor Localization and density of immune cells in the invasive margin of human colorectal cancer liver metastases are prognostic for response to chemotherapy Cancer Res 71 2011 5670 5677
6. C.J. Thiele, Z. Li, and A.E. McKee On Trk - the TrkB signal transduction pathway is an increasingly important target in cancer biology Clin Cancer Res 15 2009 5962 5967
7. W. Jin, J.J. Lee, M.S. Kim, B.H. Son, Y.K. Cho, and H.P. Kim DNA methylation-dependent regulation of TrkA, TrkB, and TrkC genes in human hepatocellular carcinoma Biochem Biophys Res Commun 406 2011 89 95
8. V. Coppola, C.A. Barrick, and E.A. Southon Ablation of TrkA function in the immune system causes B cell abnormalities Development 131 2004 5185 5195
9. L.M. McGregor, B.K. McCune, and J.R. Graff Roles of trk family neurotrophin receptors in medullary thyroid carcinoma development and progression Proc Natl Acad Sci U S A 96 1999 4540 4545
10. T.J. Musholt, C. Brehm, J. Hanack, R. von Wasielewski, and P.B. Musholt Identification of differentially expressed genes in papillary thyroid carcinomas with and without rearrangements of the tyrosine kinase receptors RET and/or NTRK1 J Surg Res 131 2006 15 25
11. A. Nakagawara, C.G. Azar, N.J. Scavarda, and G.M. Brodeur Expression and function of TRK-B and BDNF in human neuroblastomas Mol Cell Biol 14 1994 759 767
12. G.M. Sclabas, S. Fujioka, and C. Schmidt Overexpression of tropomysin-related kinase B in metastatic human pancreatic cancer cells Clin Cancer Res 11 2005 440 449
13. W. Jin, C. Yun, H.S. Kim, and S.J. Kim TrkC binds to the bone morphogenetic protein type II receptor to suppress bone morphogenetic protein signaling Cancer Res 67 2007 9869 9877
14. X. Yu, L. Liu, B. Cai, Y. He, and X. Wan Suppression of anoikis by the neurotrophic receptor TrkB in human ovarian cancer Cancer Sci 99 2008 543 552
15. J. Bouzas-Rodriguez, J.R. Cabrera, and C. Delloye-Bourgeois Neurotrophin-3 production promotes human neuroblastoma cell survival by inhibiting TrkC-induced apoptosis J Clin Invest 120 2010 850 858
16. F. Satoh, H. Mimata, and T. Nomura Autocrine expression of neurotrophins and their receptors in prostate cancer Int J Urol 8 2001 S28 S34
17. R.A. Segal, L.C. Goumnerova, Y.K. Kwon, C.D. Stiles, and S.L. Pomeroy Expression of the neurotrophin receptor TrkC is linked to a favorable outcome in medulloblastoma Proc Natl Acad Sci U S A 91 1994 12867 12871
18. A. Nakagawara, M. Arima-Nakagawara, N.J. Scavarda, C.G. Azar, A.B. Cantor, and G.M. Brodeur Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma N Engl J Med 328 1993 847 854
19. D.J. Yamashiro, X.G. Liu, and C.P. Lee Expression and function of Trk-C in favourable human neuroblastomas Eur J Cancer 33 1997 2054 2057
20. K. Nakamura, K.C. Martin, J.K. Jackson, K. Beppu, C.W. Woo, and C.J. Thiele Brain-derived neurotrophic factor activation of TrkB induces vascular endothelial growth factor expression via hypoxia-inducible factor-1alpha in neuroblastoma cells Cancer Res 66 2006 4249 4255
21. W. Jin, C. Yun, M.K. Kwak, T.A. Kim, and S.J. Kim TrkC binds to the type II TGF-beta receptor to suppress TGF-beta signaling Oncogene 26 2007 7684 7691
22. T. Sasahira, N. Ueda, and K. Yamamoto Trks are novel oncogenes involved in the induction of neovascularization, tumor progression, and nodal metastasis in oral squamous cell carcinoma Clin Exp Metastasis 2012 in press
23. T. Sasahira, T. Kirita, and U.K. Bhawal Receptor for advanced glycation end products (RAGE) is important in the prediction of recurrence in human oral squamous cell carcinoma Histopathology 51 2007 166 172
24. T. Sasahira, T. Kirita, and M. Kurihara MIA-dependent angiogenesis and lymphangiogenesis are closely associated with progression, nodal metastasis and poor prognosis in tongue squamous cell carcinoma Eur J Cancer 46 2010 2285 2294
25. D.C. Allred, J.M. Harvey, M. Berardo, and G.M. Clark Prognostic and predictive factors in breast cancer by immunohistochemical analysis Mod Pathol 11 1998 155 168
26. T. Sasahira, T. Kirita, and N. Oue High mobility group box-1-inducible melanoma inhibitory activity is associated with nodal metastasis and lymphangiogenesis in oral squamous cell carcinoma Cancer Sci 99 2008 1806 1812
27. A.M. Martelli, C. Evangelisti, F. Chiarini, C. Grimaldi, L. Manzoli, and J.A. McCubrey Targeting the PI3K/AKT/mTOR signaling network in acute myelogenous leukemia Expert Opin Investig Drugs 18 2009 1333 1349
28. L. Tessarollo Pleiotropic functions of neurotrophins in development Cytokine Growth Factor Rev 9 1998 125 137
29. T. Sasahira, Y. Akama, K. Fujii, and H. Kuniyasu Expression of receptor for advanced glycation end products and HMGB1/amphoterin in colorectal adenomas Virchows Arch 446 2005 411 415
30. C.P. Chen-Tsai, M. Colome-Grimmer, and R.F. Wagner Jr. Correlations among neural cell adhesion molecule, nerve growth factor, and its receptors, TrkA, TrkB, TrkC, and p75, in perineural invasion by basal cell and cutaneous squamous cell carcinomas Dermatol Surg. 30 2004 1009 1016
31. R.L. Elliott, and G.C. Blobe Role of transforming growth factor beta in human cancer J Clin Oncol 23 2005 2078 2093
32. E. Le Scolan, Q. Zhu, and L. Wang Transforming growth factor-beta suppresses the ability of Ski to inhibit tumor metastasis by inducing its degradation Cancer Res 68 2008 3277 3285
33. J. Wang, L. Yang, and J. Yang Transforming growth factor beta induces apoptosis through repressing the phosphoinositide 3-kinase/AKT/survivin pathway in colon cancer cells Cancer Res 68 2008 3152 3160
34. P. Schroy, J. Rifkin, R.J. Coffey, S. Winawer, and E. Friedman Role of transforming growth factor beta 1 induction of colon carcinoma differentiation by hexamethylene bisacetamide Cancer Res 50 1990 261 265
35. M. Langenskiöld, L. Holmdahl, P. Falk, E. Angenete, and M.L. Ivarsson Increased TGF-beta 1 protein expression in patients with advanced colorectal cancer J Surg Oncol 97 2008 409 415